NEW YORK, Sept. 29, 2016 -- Tabula Rasa HealthCare, Inc. (Nasdaq:TRHC), a provider of patient-specific, data-driven technology and solutions that enables healthcare organizations to optimize medication regimens, visited the Nasdaq MarketSite in Times Square today to commemorate its initial public offering (IPO) on The Nasdaq Stock Market. Tabula Rasa HealthCare’s suite of cloud-based software solutions enables healthcare organizations to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/df30ca1a-0dcd-4b5f-936d-7e4750b949ee
“With approximately 4.4 billion prescriptions filled in the U.S. in 2015, medication treatment is the most common medical intervention. We are committed to helping healthcare organizations optimize treatment and manage risk on a patient-specific, customized basis,” said Dr. Calvin H. Knowlton, CEO, Chairman, and Founder of Tabula Rasa HealthCare. “The strategic relationship with Nasdaq will enable us to continue improving the patient experience through innovative service models and fresh approaches to healthcare.”
“As the leading exchange for the world’s most ambitious healthcare companies, we are proud to be a champion for new technology breakthroughs and discoveries in the industry,” said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq. “With unmatched support to our listed companies, shareholders and investors, we are excited to be the listing partner of Tabula Rasa HealthCare as the company takes on the next chapter of its journey.”
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Information about the company is provided by the company or comes from the company’s public filings and is not independently verified by Nasdaq. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and more than 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
- NDAQG -
Media Relations Contacts: Stephanie Lowenthal (646) 441-5073 [email protected] Emily Pan (646) 441-5120 [email protected]


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 



